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Abstract 
Metabonomics/Metabolomics is an important science for the understanding of 
biological systems and the prediction of their behaviour, through the profiling of 
metabolites. Two technologies are routinely used in order to analyse metabolite 
profiles in biological fluids: nuclear magnetic resonance (NMR) spectroscopy and 
mass spectrometry (MS), the latter typically with hyphenation to a chromatography 
system such as liquid chromatography (LC), in a configuration known as LC-MS. 
With both NMR and MS-based detection technologies, the identification of the 
metabolites in the biological sample remains a significant obstacle and bottleneck. 
This article provides guidance on methods for metabolite identification in biological 
fluids using NMR spectroscopy, and is illustrated with examples from recent studies 
on mice. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
NMR-Based ID of Metabolites: A Guide  Page 2 
 
 
Keywords 
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Highlights (N.B. this needs cutting out into a separate document later) 
1. many simple metabolites can be identified in biofluids using 1D 1H NMR 
methods 
2. metabolites at lower levels and with more complex structures will require 2D 
NMR approaches for identification 
3. metabolite databases such as the HMDB are helpful for metabolite 
identification 
4. users need to be aware of the possibility of errors in metabolite databases 
5. metabolite identification carbon efficiency (MICE) helps measure known 
metabolite identification confidence 
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1. Introduction 
 
Metabonomics is defined as ‘the quantitative measurement of the multiparametric 
metabolic response of living systems to pathophysiological stimuli or genetic 
modification’ and is concerned with the study of the metabolic response of organisms 
to disease, environmental change or genetic modification.[1] The similar term 
metabolomics [2] was defined later and is now used interchangeably. In contrast to 
the interventional definition of metabonomics, metabolomics has an observational 
definition which is difficult if not impossible to achieve: ‘a comprehensive analysis in 
which all the metabolites of a biological system are identified and quantified’.[2] In 
this work we will use the original term throughout. Metabonomics has many areas of 
application including biology and medicine [3] with new developments such as 
pharmacometabonomics (the ability to predict drug responses prior to drug dosing) 
and the more general area of predictive metabonomics, emerging recently.[4-7]  
 
There are many stages to a well-designed metabonomics experiment including: 1) 
definition of study aims and experimental design, 2) ethical approval of the study, 3) 
sample collection and storage, 4) sample preparation, 5) data acquisition, 6) data 
quality control, 7) spectroscopic data pre-processing (for NMR data this would 
include zero-filling, apodisation, Fourier transform, phasing, baseline correction and 
referencing), 8) statistical data pre-processing including peak alignment, scaling and 
normalisation, 9) statistical analysis of the data to interrogate e.g. differences in 
metabolite profiles due to a drug treatment, 10) identification of the metabolites that 
are responsible for the metabolite profile differences, 11) biological/biochemical 
interpretation of the role of those metabolites, including pathway analysis and 12) 
reporting of results and deposition of the data. 
 
Many of the metabonomics study elements above have excellent literature reviews 
and references available to assist effective study execution.[8-20] However, the 
identification of the key biomarkers or metabolites that are responsible for 
discriminating between different groups in a study (Stage 10 above) is non-trivial for 
both NMR [15,21-28] and MS-based [28-34] metabonomics experiments. This guide 
aims to provide an insight into the methodologies that can be used for NMR-based 
metabolite identification in the course of a metabonomics project. It is assumed that 
the reader is familiar with the basics of NMR spectroscopy: many excellent books on 
the topic are available.[35-38] The focus of this guide is on the use of 
1
H NMR, or 
1
H 
NMR-detected heteronuclear 2D NMR experiments, for metabolite identification in 
metabonomics experiments on biological fluids. 
 
 
2. Molecular Structure Information from 1D NMR Spectra of Metabolites 
 
A surprising amount of information is available from a one-dimensional (1D) 
1
H 
NMR spectrum, including: 1) chemical shifts, 2) signal multiplicities, 3) homonuclear 
(
1
H - 
1
H) coupling constants, 4) heteronuclear coupling constants (typically 
14
N - 
1
H 
or 
31
P - 
1
H), 5) the first order or second-order nature of the signal, 6) the half 
bandwidth of the signal, 7) the integral of the signal and 8) the stability of the signal 
(changes in the integral with time). We will not cover: 9) spin-lattice relaxation times 
(T1s) or 10) spin-spin relaxation times (T2s). Whilst an appreciation of both these 
latter features is critical for the conduct of all NMR experiments, and differentiation 
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of short from long T2s is fundamental in the Carr-Purcell-Meiboom-Gill (CPMG) 
spin-echo pulse sequence for plasma analysis, these features are of minor importance 
per se for metabolite identification. We will deal with each of the first 8 features in 
turn and see how they can be used to assist metabolite identification. 
 
2.1 
1
H NMR Chemical Shifts 
 
Each chemically distinct hydrogen nucleus in each metabolite in a biological sample, 
such as a biofluid, will exhibit an NMR signal at a characteristic resonance frequency, 
which is measured as a chemical shift relative to a standard compound. For example, 
in metabonomics studies of urine, it is common to add the reference material such as 
3-(trimethylsilyl)-2,2',3,3'-tetradeuteropropionic acid (usually abbreviated to TSP) or 
deuterated forms of 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) or its sodium 
salt, and define the chemical shift of the TSP or DSS methyl resonances as 0 ppm. 
Our preference is to use TSP as the reference material in biofluids without significant 
protein concentrations. The normal reference material for NMR spectroscopy in 
organic chemistry, tetramethylsilane (TMS) is rarely used in metabonomics studies, 
as it is insoluble in aqueous solutions.  
 
The exact chemical shift of the NMR signal of a hydrogen nucleus in a metabolite is 
independent of the applied field strength, is highly reproducible and precisely 
characteristic of that nucleus, in that metabolite, in the particular matrix conditions. 
For biofluids such as blood plasma or serum, where DSS or TSP may become bound 
to macromolecule components, it is common to reference the spectra to the H1’ 
anomeric proton of the alpha anomer of glucose at 5.233 ppm, to avoid variation in 
reference intensity and position due to binding.[39] However, care must be taken with 
temperature control as this signal has high temperature sensitivity and indeed, has 
been used as an NMR thermometer.[40] 
 
When comparing the experimental 
1
H NMR chemical shifts of hydrogens in 
metabolites in intact biofluids with those of the corresponding pure reference 
standards in aqueous solution, it is usual for values to agree within 0.03 ppm. One of 
the strengths of NMR spectroscopy is that the chemical shifts are exquisitely sensitive 
to structural and environmental change. Indeed, sensitivity of chemical shifts to pH 
change can be used to distinguish or identify metabolites, especially those containing 
ionisable functional groups.[41] Whilst this is an excellent feature in terms of 
decreasing the likelihood of two similar molecules having identical 
1
H NMR spectra, 
it does mean that for some metabolites, environmental change can have a significant 
effect on the spectra, including the 
1
H NMR chemical shifts. A classic case of this 
sensitivity to the environment occurs for the diastereotopic methylene hydrogens in 
citric acid. Changes in pH between samples will alter the ionisation of the carboxylate 
groups in citric acid and thus affect the chemical shifts of the methylene hydrogens. In 
addition, it is well known [3] that citric acid can chelate metal ions such as calcium, 
magnesium and sodium. Thus, even if biofluid samples are buffered effectively to a 
constant pH, changes in metal ion concentrations between samples, which are not 
readily apparent by 
1
H NMR, may have a significant effect on the chemical shifts and 
the half bandwidths of the signals of the methylene hydrogens of citric acid and also 
any other metabolites with similar properties. This effect is observed in Figure 1. 
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Figure 1: an expansion of the 600 MHz 
1
H NMR spectrum of the urine of four, 30 week old, male 
C57BL/6 mice, in the region of the doublet signals of citrate at ca 2.70 and 2.56 ppm. Even though the 
urine is buffered to pH 7.4, there are differences in the chemical shifts of the citrate signals between the 
four urine samples and noticeable differences also in half bandwidth, with the signals of mouse 1 
(bottom spectrum) being especially broadened. The ‘roofing’ of the doublet citrate signals towards one 
another is illustrated by the arrows above the citrate resonances of mouse 4. See section 2.6 on 2
nd
 
order effects. 
 
Many general resources are available which correlate the relationships between 
chemical structure and NMR chemical shifts [36,42], including web resources [43], 
whilst more specific metabonomics-focused databases are covered in Section 4.3 
below. As for 
13
C NMR chemical shifts (see Section 2.2 below), it is also possible to 
calculate 
1
H NMR shifts, especially in discrete series.[43] 
 
2.2 
13
C NMR Chemical Shifts 
 
Most metabonomics experiments are conducted with 
1
H NMR detection. However, 
the 2D 
13
C, 
1
H HSQC NMR (Section 3.5 below) and 2D 
13
C, 
1
H HMBC NMR 
(Section 3.6) experiments which correlate 
1
H NMR chemical shifts with 
13
C NMR 
chemical shifts over 1-bond (HSQC) or 2 to 3 bonds (HMBC) are very important for 
metabolite identification, as they enable the determination of the 
13
C NMR chemical 
shifts of metabolites, so an appreciation of the nature of 
13
C NMR chemical shifts is 
required. One key feature of 
13
C NMR chemical shifts is their much larger range of 
values compared with 
1
H NMR chemical shifts. For common metabolites 
13
C NMR 
chemical shifts occupy a huge range of values from ca 10 ppm for methyl carbons 
such as C4 in butanone to ca 222 ppm for the ketone (C2) carbon in the same 
molecule. Thus the range of 
13
C NMR chemical shifts is ca 20 times that of 
1
H NMR 
and this is the reason that their measurement is so important in metabolite 
identification: they are much more sensitive to small changes, or more remote 
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changes in molecular structure, including stereoisomerism, than 
1
H NMR chemical 
shifts.  
 
For simple molecules 
13
C NMR chemical shifts can be calculated by hand using 
simple additivity tables.[44] For example in simple substituted benzenes such as para-
cresol (1-hydroxy-4-methylbenzene), the 
13
C NMR chemical shifts of all of the 
carbons can be calculated by adding the known substituent effects of hydroxyl and 
methyl groups [44] to the chemical shift of benzene in an additive fashion. 
 
 
The substituent parameters for an hydroxyl group added to a benzene ring are +26.9 
(ipso), -12.7 (ortho), +1.4 (meta) and -7.3 ppm (para position). For a methyl group the 
corresponding parameters are +9.3 (ipso), +0.8 (ortho), 0.0 (meta) and -2.9 ppm 
(para).[44] The accepted 
13
C NMR chemical shift of benzene is 128.5 ppm. Even if 
the molecule para-cresol was not in a metabolite database, we could calculate the 
13
C 
NMR shifts with some degree of precision. For C2 and C3 the calculated shifts would 
be as follows: 
 
δC2 = 128.5 -12.7 (OH ortho) + 0 (methyl, meta) = 115.8 ppm 
 
δC3 = 128.5 +1.4 (OH meta) + 0.8 (methyl, ortho) = 130.7 ppm 
 
 
For comparison, the actual values in the HMDB [45] for para-cresol, HMDB01858, in 
water at pH 7.0 are 117.9 and 132.8 ppm for C2 and C3 respectively. Modern NMR 
data processing software such as MNova [46] possesses more sophisticated 
1
H, 
13
C, 
and multinuclear NMR chemical shift calculation and prediction algorithms. The 
algorithm in MNova 10.0.0 predicted shifts of 117.6 and 130.0 ppm for C2 and C3 
respectively, a very good fit to the real data for C2, but not quite as good as the simple 
hand calculation for C3. MarvinSketch v 6.1.1 from ChemAxon [47] also has 
1
H and
 
13
C NMR chemical shift calculation capabilities and it gave 115.3 and 130.0 ppm for 
C2 and C3 respectively. Calculations such as these can be useful when information 
about metabolites of interest is not in the existing databases: a common occurrence. 
However, users must be aware that these calculations are approximate, with precision 
varying according to the complexity of the metabolite and the relationship of the 
structure of the metabolite to the molecules in the prediction calculation database, or 
to those used to derive the substituent tables. In general a precision of better than +/- 5 
ppm is usually achieved for 
13
C resonances. 
 
OH
CH
3
3
2
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It is beyond the scope of this guide to discuss factors that influence 
13
C NMR shifts in 
any detail. However, the key factors include: hybridisation of the carbon atom (sp3, 
sp2 or sp hybridised), inductive substituent effects and mesomeric effects.[43,48-52] 
 
2.3 
1
H NMR Multiplicities 
 
The multiplicity is the pattern of peaks that is observed for a particular hydrogen 
signal in the 
1
H NMR spectrum. In a first order 
1
H NMR spectrum, the frequency 
difference between the resonances of coupled hydrogens is large (>> 10 times) 
relative to the value of the coupling constant between them. In those circumstances, 
the signals exhibit first order coupling patterns, which obey an n+1 splitting rule, 
where n is the number of equivalent coupling partners. For instance, methyl groups 
such as those of lactic acid which couple with one hydrogen on an adjacent carbon via 
a homonuclear, 3-bond vicinal coupling, 
3
JH,H, will be split into a doublet signal (1 + 1 
= 2). Correspondingly, the signal of the lactate methyne CH proton will be split into a 
4-line quartet due to the interaction with the 3 equivalent methyl hydrogens (3 + 1 = 
4). The intensity ratios of these multiplet signals follow Pascal’s triangle [35] , being 
1:1, 1:2:1, and 1:3:3:1 for a doublet, triplet and quartet respectively. An example of a 
1:2:1 triplet from one of the methylene CH2 groups in 2-oxoglutaric acid is clearly 
observed at 2.45 ppm in the 
1
H NMR spectra of the urines of the mice in Figure 1.  
 
If a particular hydrogen is coupled to more than one group of hydrogens, then more 
complex coupling patterns or multiplicities are observed. For instance, the CH2-3 
methylene signal from the butyryl chain of N-butyrylglycine resonates as a triplet of 
quartets as it is coupled to both the terminal CH3-4 protons and the CH2-2 protons 
adjacent to the C1 amide carbon. If the coupling constants involved were non-equal 
then up to 12 lines could be observed in this case (4 x 3). However, in this case, the 
CH3-4 to CH2-3 coupling constant (7.4 Hz) is almost equal to the CH2-2 to CH2-3 
coupling constant (7.5 Hz) and the C3 methylene signal resonates as a pseudo-sextet 
due to signal overlap (Figure 2).  
 
 
Figure 2: an expansion of the 600 MHz 
1
H NMR spectrum of the urine of a male, 15 week old, 
C57BL/6 mouse, in the region of the signal from the CH2-3 methylene protons of N-butyrylglycine at 
ca 1.62 ppm (dots). This pseudo-sextet signal is actually a triplet of quartets with the two 
3
JH,H 
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couplings being almost equal in magnitude (7.4 and 7.5 Hz) resulting in overlap of many of the lines. 
The molecular structure of the metabolite is superimposed. 
 
The analysis of signal multiplicities, simple and complex [36,43], is important for the 
identification of metabolites. Multiplicity-editing spin-echo NMR experiments can 
also be used to distinguish between signals with different multiplicities and this can 
be helpful in metabolite identification. A good example is the use of spin-echo 
1
H 
NMR in the identification of novel penicillin metabolites, where the characteristic 
singlet signals of the penicillin gem-dimethyl groups can be easily identified by Hahn 
spin-echo methods.[53,54] Many spectra do not obey first order requirements 
however and two main consequences arise from this; multiplicity intensities may be 
distorted, or in extreme cases additional lines may occur in the multiplets: see Section 
2.6 below.  
 
2.4 Homonuclear 
1
H, 
1
H Coupling  
 
Scalar coupling can occur between all non-equivalent hydrogen atoms in a metabolite. 
The key requirement here is magnetic non-equivalence. Hydrogens that are equivalent 
by molecular symmetry, such as the methyne hydrogens in tartaric acid, or equivalent 
by virtue of fast rotation, such as those of methyl hydrogens, will not show scalar 
coupling between themselves. Indeed the two methyne hydrogens of 2R, 3R-tartaric 
acid resonate as a characteristic, sharp singlet at 4.34 ppm in urine. 
 
   
 
The detection of the presence of scalar coupling between two hydrogens in a 
metabolite is very important in metabolite identification, as the magnitudes of the 
coupling constants are characteristic of the electronic pathway between the two 
hydrogens or groups of hydrogens. Scalar coupling is transmitted via the bonding 
electrons in the metabolites and drops off in magnitude as the number of bonds 
between the hydrogens increases. Most of the homonuclear scalar couplings observed 
in metabolites will be two-bond geminal couplings (
2
JH,H) between hydrogens on the 
same carbon, or three-bond, vicinal couplings (
3
JH,H) between hydrogens on adjacent 
carbons in a metabolite. In general, 2-bond geminal couplings are larger in magnitude 
that 3-bond, vicinal couplings. However, geminal couplings are affected by the 
hybridisation of the carbon atom and by the electronegativity of substituents, and in 
some alkenes, such as R1R2C=CH2 the 
2
JH,H value for the terminal =CH2 will be close 
to 0 Hz. In passing, we should note that most geminal couplings are negative in sign 
and most vicinal couplings are positive, but this is not relevant for most analyses and 
we will ignore this feature henceforth. The large magnitude of geminal couplings in 
sp
3
CH2 groups is well illustrated by the spectrum of citrate shown in Figure 1, where 
the geminal 
2
JH,H coupling is ca 16.2 Hz. By contrast, the 3-bond, vicinal coupling 
between the C3-CH2 group and its adjacent methyl and methylene group neighbours 
OH
O
OH
OH
HO
O
2R, 3R-tartaric acid
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in N-butyrylglycine is ca 7.4 and 7.5 Hz respectively (Figure 2). These 
3
JH,H values 
are smaller and are typical of the values for free-rotating aliphatic moieties. 
 
The values of vicinal couplings are particularly sensitive to stereochemistry in 
relatively rigid systems and this is well illustrated by metabolites such as D-glucose, 
which exists as two anomers in slow exchange with one another, so that separate 
signals are observed for each anomer. 
 
 
 
The anomeric proton at C1 in the alpha anomer is in an equatorial position on the 6-
membered pyranose ring and has a modest 
3
JH,H coupling of ca 3.7 Hz to the axial H-2 
(equatorial-axial coupling). By contrast, the coupling between H2 and H3 (both axial) 
has a value 
3
JH,H ca 9.8 Hz because this is a favoured, di-axial coupling. Thus the 
magnitude of coupling constants can give information on the type of coupling and the 
stereochemistry of the interacting hydrogens. In addition to this, the values of 
coupling constants are affected by the electronegativity of groups in their vicinity, due 
to their impact on the electrons that transmit the coupling.[43] 
 
If 
1
H NMR spectra are acquired with good spectral resolution, good digital resolution 
and good lineshape, it is possible to observe 4-bond, 5-bond and even 6-bond 
hydrogen-to-hydrogen couplings, 
4
JH,H , 
5
JH,H and 
6
JH,H, in biofluids. For example, in 
cis-aconitic acid, it is usual to observe the olefinic proton at ca 5.74 as a triplet with 
4
JH,H ca 1.4 Hz due to long-range, 4-bond coupling to the equivalent methylene CH2 
hydrogens across the double bond (Figure 3).  
 
 
HO
OH
O
OH
HO
HO
H
H
H
2
1
3
alpha-D-glucose
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Figure 3: an expansion of the 600 MHz 
1
H NMR spectrum of the urine of pooled, male C57BL/6 mice 
at 15 weeks age, in the region of the signal from the olefinic proton of cis-aconitic acid at ca 5.74 ppm. 
The signal is a triplet due to a long-range, 4-bond, 
4
JH,H coupling of ca 1.4 Hz to the two equivalent 
methylene hydrogens. The 1:2:1 nature of the triplet is clear, even though it is superimposed upon the 
very broad signal from urea at ca 5.80 ppm.  
 
In the trans-aconitic acid isomer, the olefinic proton at 6.60 ppm is a triplet with a 
smaller 
4
JH,H ca 0.8 Hz coupling. Note the enormous sensitivity of the chemical shift 
to the geometry of the double bond: the olefinic proton shifts nearly 0.9 ppm just from 
the change of double-bond geometry, and the change in the coupling value for 
4
JH,H is 
also diagnostic. 
 
 
2.5 Heteronuclear 
1
H, X Coupling  
 
These couplings are less common but will occur in phosphorous-containing 
metabolites such as adenosine monophosphate, where the presence of the NMR-
active, 100% abundant, spin I =1/2, 
31
P isotope will give rise to additional 3-bond and 
4-bond 
3
JP,H and 
4
JP,H couplings to the ribose ring protons, that are highly 
diagnostic.[55] Another less-commonly observed heteronuclear coupling in 
metabolites is due to the 99.6% natural abundance 
14
N isotope which is NMR-active 
but quadrupolar, with spin quantum number I = 1. Due to quadrupolar relaxation, 
couplings to 
14
N are not often observed, but in a symmetrical environment, the effects 
of quadrupolar relaxation are reduced and small couplings may be observed and these 
can also be critical for metabolite identification. For instance, in choline 
(HMDB00097), the almost symmetrical environment around the nitrogen allows the 
observation of a small 
2
JN,H coupling of ca 0.6 Hz (1:1:1 triplet due to spin quantum 
number I = 1) to the methyl hydrogens due to 2-bond coupling to the 
14
N. So, in this 
unusual case, the methyl signal is a narrow triplet instead of the expected singlet 
(Figure 4).   
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Figure 4: an expansion of the 600 MHz 
1
H NMR spectrum of the pooled urine of male C57BL/6 mice 
at 15 weeks age, in the region of the signal from the methyl protons of choline (structure 
superimposed) at ca 3.20 ppm. The signal is a 1:1:1 triplet (dots) due to a 2-bond coupling of ca 0.6 Hz 
to the 
14
N nucleus. Interestingly, the well-resolved doublet at ca 3.13 ppm is due to the methylene 
protons of cis-aconitic acid with 
4
JH,H coupling of ca 1.4 Hz (see also Figure 3). The spectrum has been 
zero filled to 131,072 points and resolution enhanced by Gaussian multiplication, prior to Fourier 
transformation. 
 
 
2.6 Second-Order Effects and Strong Coupling in 
1
H NMR Spectra  
 
As the frequency separation in Hertz between coupled 
1
H NMR signals decreases to 
less that ca 10 times the value of the coupling constant between them, distortions to 
expected multiplet peak intensities start to occur in the spectra. The spins are said to 
exhibit ‘strong coupling’, or to be in a second-order system. The spectra take on 
appearances that are different from those of systems that exhibit ‘weak coupling’ or 
are in first-order systems. Rather than being a problem, this is actually an aid to 
spectral interpretation and metabolite identification, as follows. In the simple case of 
two, non-equivalent hydrogen atoms coupling with one another, the intensity 
distortion is such that the doublets slope towards one another in an effect called 
‘roofing’. This is well illustrated in the spectra of the two, non-equivalent methylene 
protons in citric acid shown in Figure 1. The chemical shift difference between the 
resonances at 2.70 and 2.56 ppm is 0.14 ppm, which equates to ca 84 Hz at 600 MHz 
operating frequency. The 
2
JH,H coupling is ca 16.2 Hz and therefore the ratio of the 
frequency separation to the coupling constant is 84/16.2 = 5.2. This two-hydrogen 
spin system is formally designated AB: the two letters indicate that there are two 
distinct spins or hydrogen atoms involved in the coupling system; the closeness of the 
letters in the alphabet indicates that their chemical shifts are close in frequency. The 
roofing of the signals is clear to see in Figure 1 and provides a way, without using 2D 
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COSY NMR or any decoupling techniques, to determine that these hydrogens are 
coupled to one another; an important and often overlooked benefit of this feature. In a 
two-spin system that is first order, the nomenclature would be AX instead of AB to 
indicate that the two hydrogens are widely separated in chemical shifts, relative to the 
size of their mutual coupling. 
 
If the spin system is more complex, or the ratio of signal frequency separation to 
coupling constant becomes much smaller, the intensity distortions can become more 
significant and in extreme cases involving three spins or more, additional lines are 
seen in the resonances which are not always interpretable by first order analysis. This 
effect is commonly observed in the NMR signals for the aromatic hydrogens in 
symmetrically substituted benzene rings (Figure 5).  
 
 
Figure 5: two versions of the 600 MHz 
1
H NMR spectrum of an authentic sample of the metabolite 
para-cresol sulphate in deuterated phosphate buffer at pH 7.4, in the region of the signals from the 
aromatic hydrogens: 1) with a standard 0.3 Hz line-broadening and 2) resolution-enhanced using a 
Lorentzian to Gaussian transformation. The signal of the H2, H6 protons appears as a complex, second-
order multiplet at ca 7.22 ppm, instead of a first-order doublet. The signal of the H3, H5 protons at ca 
7.29 ppm displays additional complexity due to coupling to the methyl protons via a 4-bond coupling, 
in addition to the extra lines, clearly visible in this second-order system. 
 
For metabolites such as para-cresol sulphate, the phenomenon of magnetic non-
equivalence appears.[37] The hydrogens on C2 and C6 are chemically equivalent by 
symmetry, as are those on C3 and C5. However, these pairs of hydrogens are NOT 
magnetically equivalent. The reason for this is as follows: H2 is ortho to H3 and has a 
3-bond coupling to it. By contrast, the chemically equivalent proton H6 is ortho to H5 
and para to H3. Thus, in terms of their nuclear magnetic interactions, these hydrogens 
are non-equivalent and this has consequences. The frequency difference between the 
signals of H2 and H6 is 0 Hz by definition and they are coupled by a favourable, 
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long-range ‘W’ coupling over 4-bonds. Thus, the frequency separation to coupling 
ratio is 0, no matter what the value of the coupling constant and the resultant spectra 
are second-order.[37] This spin system is designated AA’BB’, where A and A’ 
represent H2 and H6 and the apostrophe signifies a chemically equivalent but 
magnetically non-equivalent nucleus. B and B’ are H3 and H5 and the closeness of 
the letters in the alphabet is deliberate and signifies the closeness of the chemical 
shifts of these two groups of spins. In these extreme cases, additional lines appear in 
the spectra and the resonance patterns may not be readily interpretable by first order 
analysis. Instead of a simple pair of doublets, as might be expected, a complex pattern 
appears (Figure 5). Typically, a computational, spin simulation program is used to 
calculate the spectrum and this is now a routine procedure. An important point to 
appreciate is that it may not be straightforward to extract chemical shifts or coupling 
constants from second-order spectra without spin simulation: see Section 2.10 and 
Figure 6. 
 
2.7 The Half Bandwidth of NMR signals 
Another feature that provides information on the structure and the dynamics of 
metabolites is the half bandwidth of their signals. The half bandwidth, Δν1/2 of a 
signal is related to the real spin-spin relaxation time of the hydrogen giving rise to that 
signal according to equation 1: 
 
Δν1/2 = 1/π . T2*   Eqn. 1 
 
… where T2* is the real spin-spin relaxation time that takes into account underlying 
molecular relaxation processes, plus the effect of field inhomogeneities and the 
influence of factors such as the presence of paramagnetic species (including dissolved 
oxygen gas) in the sample. T2* can be shortened by interaction with quadrupolar spins, 
such as 
14
N and by chemical exchange. In the case of chemical exchange between two 
forms of a metabolite, A and B, the lifetime of a spin in species A is necessarily 
limited to the lifetime of species A, as a maximum. Exchange-broadening of the 
signals will occur when the exchange rate in Hertz between forms A and B is of the 
same magnitude as the chemical shift difference between the corresponding 
hydrogens in A and B. The broadening effects of exchange with water, quadrupolar 
relaxation and unresolved couplings to 
14
N can be quite large, as can be seen in Figure 
3, where the hydrogen signal from urea has a half bandwidth of ca 50 Hz, in contrast 
to the much narrower linewidth of the olefinic proton in cis-aconitic acid, where all of 
these effects are absent and consequently the non-exchanging hydrogens have much 
larger T2* values.. 
 
2.8 The Integral of NMR signals 
 
When NMR experiments are run with sufficient delay times in between the 
acquisition of each successive free induction decay, the nuclei under observation will 
enjoy close to full spin-lattice relaxation. Under these conditions, the signals will not 
be partially saturated,[35] and the area of a methyl (CH3) signal in a metabolite in a 
biofluid will be precisely three times that of a methyne (CH) signal in the same 
metabolite in the same sample. NMR spectroscopy is thus an inherently quantitative 
technique and this is a huge advantage for the conduct of metabonomics experiments. 
It should be noted however that most NMR-based metabolic profiling experiments do 
not achieve full relaxation with the delay times typically used. Even so, the situation 
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is in stark contrast to MS-based profiling, where the intensities of signals from 
metabolites may be significantly suppressed or enhanced by the presence of other 
metabolites in the sample [56] and internal reference standards are required in order to 
achieve quantitation.  
 
Quantifying the level of a metabolite in a biological fluid such as urine, by 
1
H NMR 
spectroscopy, can be very difficult, because of spectral crowding and spectral overlap, 
and great care is required either with line fitting or direct integration quantification 
approaches. However, when careful approaches are taken, the analytical precision of 
the methodology is high [12,57,58] and this is critical for the statistical analysis of the 
data and the reliable discovery of discriminating biomarkers: see Section 4.1. 
 
2.9 The Stability of NMR signals 
 
Generally, the metabolic profile of a biological fluid is stable over a significant period 
of time at room temperature, and certainly stable enough for the acquisition of routine 
1D and 2D 
1
H NMR data. However, there are exceptions. Some biological fluids are 
inherently unstable. A good example of this is human seminal fluid, where, post-
ejaculation, enzymatic reactions take place that cause the biochemical transformation 
of some metabolites.[59] In addition, if a sample such as animal urine, has been in 
contact with animal faeces at any stage, it will be microbiologically contaminated and 
potentially unstable. Bacterial growth in a urine sample, for instance, will result in the 
transformation of certain metabolites into new products, as the bacteria scavenge the 
biofluid for fuel sources. It is common practice to add anti-bacterial agents such as 
sodium azide [8,16] to inhibit the growth of the bacteria. However, in our experience, 
even in the presence of sodium azide at 9 mM, bacterially-mediated metabolite 
transformations can still occur in mouse urine if kept at room temperature for 
extended periods, and hence, signals will be unstable over time: the signals of 
fermentation substrates will decrease, whereas those of products will increase. See 
Section 4.6, Biochemical Transformation and In Vitro Fermentation of Biofluids to 
Aid Metabolite Identification. A major improvement in this area has occurred with the 
development of cooled sample changers, such as the SampleJet system from Bruker 
Corporation (Billerica, Massachusetts, USA), that keeps queued samples at 4 C prior 
to their insertion into the NMR magnet, thus minimising sample instability. 
 
2.10 Interpretation of 1D 
1
H NMR Spectra and Metabolite Identification 
 
Metabolites that are present at relatively high concentrations or that have distinctive 
signals in relatively uncrowded spectral regions can be identified by inspection from a 
simple 1D 
1
H NMR spectrum. This can be done manually by the spectroscopist 
interpreting the data, or with the assistance of software such as Chenomx NMR Suite 
(Chenomx, Edmonton, Canada), which has the advantage of a database of standard 
metabolite spectra at a variety of magnetic field strengths and a variety of pH 
values.[60] Obvious metabolites include citric acid (see Figure 1) where the 
(somewhat variable) chemical shifts and large ‘roofed’ geminal couplings of the 
methylene protons are unmistakeable. Another easily identifiable metabolite is 
hippuric acid, whose second-order aromatic proton resonances between 7.9 and 7.4 
ppm provide an unmistakable ‘fingerprint’ for identification (Figure 6).  
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Figure 6: 1) the 600 MHz 
1
H NMR spectrum of the urine of a 30 week old, male, flavin mono-
oxygenase 5 (FMO5) knockout mouse [61] in the region of the aromatic signals from hippuric acid 
(structure inset). The spectrum is resolution enhanced by Gaussian multiplication. 2) A spin simulation 
of the aromatic signals from hippuric acid using the MNova spin simulation function. A good 
approximation to the complex, second-order signals was obtained. The complexity of the two ortho and 
two meta hydrogen signals is due to the fact that whilst these hydrogens are chemically equivalent 
(within each pair), they are magnetically non-equivalent and are part of a five hydrogen AA’BB’M 
spin system (see Section 2.6). Signals from 3-indoxyl sulphate and other metabolites are present in the 
real spectrum (1). 
 
Certain other metabolites have distinctive singlet signals at characteristic chemical 
shifts, such as the methyl hydrogens of methylamine, dimethylamine and 
trimethylamine at ca 2.61, 2.73 and 2.88 ppm respectively. However, little 
information is present in the 1D 
1
H NMR spectrum of these metabolites: just one 
singlet resonance. Hence, it is advisable to check the assignments of these types of 
resonances using a 2D 
13
C, 
1
H HSQC experiment to verify that the methyl carbons 
have the expected chemical shifts of ca 27.7, 37.6 and 47.6 respectively for 
methylamine, dimethylamine and trimethylamine. Note the uniform ca 10 ppm 
increase in methyl carbon chemical shift as each methyl group is added, due to the 
additive, two-bond or beta substituent effect. 
 
The identification of metabolites present at relatively low levels, or that have signals 
that are partially or completely overlapped, will be difficult by 1D NMR methods and 
the use of two-dimensional NMR spectroscopic methods is required. In Section 4.7, 
we will review how much information is required in order to consider the 
identification of a known metabolite confident. 
 
3. Molecular Structure Information from Two-Dimensional (2D) NMR 
Spectroscopy  
NH
O
O
H
H
OH
H
H
H
H
H
ortho%(o)%
para%(p)%
meta%(m)%
o%
m%
p%
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
NMR-Based ID of Metabolites: A Guide  Page 17 
 
 
3.1 Introduction to 2D NMR spectroscopy 
 
In a 1D NMR spectrum the NMR signals are acquired as a function of a single time 
variable (t2) in a free induction decay (FID), typically over 65,536 data points at a 
1
H 
frequency of 600 MHz. This FID arises from the induction of an electric current in the 
receiver coils of the NMR probe by the excited nuclear magnetisations: there is no 
emission event detected in NMR. Fourier transformation of this FID gives rise to the 
conventional 1D 
1
H NMR spectrum in which NMR signal intensity (y-axis) is plotted 
as a function of chemical shift (x-axis). By contrast in a 2D NMR experiment, a 
second time dimension (t1) is artificially created by the deliberate incrementing of a 
time delay, known as the evolution time, between two of the radiofrequency pulses in 
the pulse sequence used. An FID is collected for each of m values of the evolution 
time, such that at the end of the experiment, m x FIDs have been collected, each 
containing n data points. Double Fourier transformation of this data set over both t2 
and t1 results in a single 2D NMR spectrum in which signal intensity (z-axis) is 
plotted as a function of two orthogonal signal frequency axes; f2 and f1 corresponding 
to t2 and t1 in the time domain (x and y respectively). The spectra are typically 
displayed as contour plots where signal intensity is represented by contour lines, in 
much the same way that the heights of mountains and hills are represented on maps. 
 
We shall not go into the details of the design of the 2D NMR pulse sequences, nor the 
analysis of how those pulse sequences give the resulting spectra, as many excellent 
reference works are available in this area.[35,37]  
 
 3.2 2D 
1
H J-Resolved (JRES) NMR Spectroscopy  
 
The 2D 
1
H J-Resolved NMR Spectroscopy (JRES) experiment is one of the simplest 
2D NMR experiments and one of the most useful for the analysis of the complex 
1
H 
NMR spectra of biological fluids.[21,22,62] The experimental radiofrequency pulse 
sequence is simply: RD - 90
0
H - t1/2 - 180
0
H - t1/2 - FID, where RD is a relaxation 
delay. The second proton pulse (180
0
H) occurs in the middle of the incremented 
evolution time (t1). In the resulting 2D 
1
H NMR JRES spectrum, the chemical shifts 
run along the first frequency dimension, f2, as normal, and homonuclear coupling 
constants are modulated (spread out) across a second frequency dimension, f1. For 
simple, first order spin systems, no new signals are created: the existing signals are 
just spread out across two frequency dimensions instead of one. This has a 
tremendous effect in reducing signal overlap in crowded spectral regions. The spectra 
are typically tilted by 45
0
 so that all the signals of a homonuclear multiplet appear at 
the exact same chemical shift. The projection of the 2D spectrum onto the chemical 
shift dimension, f2, is then effectively a broadband proton-decoupled proton NMR 
spectrum, in which each 
1
H resonance is a singlet. It is important to note that 
heteronuclear couplings are unaffected by the 
1
H 180
0 
pulse in the 2D 
1
H NMR JRES 
experiment and these are not modulated across the second dimension of the 2D 
spectrum.[55] 
 
The tremendous improvement in signal resolution by spreading the NMR signals out 
across a second dimension is clearly illustrated in Figure 7. In the 1D 
1
H NMR 
spectrum of the urine of an FMO5 knockout mouse [61], the triplet methyl signal for 
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N-butyrylglycine (three blue circles at 0.926 ppm) is overlapped with the doublet 
methyl signal for isovaleric acid (two red squares at 0.916 ppm). By contrast in the 
2D 
1
H JRES NMR spectrum, these signals are completely resolved from one another. 
 
 
 
Figure 7: the low frequency region of the 600 MHz 2D 
1
H J-resolved NMR spectrum of the urine of a 
male, 30 week old, FMO5 knockout mouse [61] displayed as a contour plot underneath the 
corresponding 1D 
1
H NMR spectrum. The overlapping signals from the triplet methyl group of N-
butyrylglycine (0.926 ppm, three blue circles and downward arrows) and the doublet methyl group of 
isovaleric acid (0.916 ppm, two red squares and upward arrows) are completely resolved in the 2D 
JRES NMR spectrum. The spectrum is tilted by 45
0
, so that all the signals of each multiplet appear at 
the same chemical shift, and it is symmetrised. 
 
The simple interpretation of 2D 
1
H JRES NMR spectra only applies for first order 
systems in which there is weak coupling. If strong coupling exists (a second-order 
system) then artefacts can appear in the spectra.[63] This occurs because in a strongly 
coupled system the second 
1
H pulse (a 180
0
 or π pulse) will cause not just the 
modulation of the signals of a homonuclear-coupled spin across the second 
dimension, according to the size of its spin couplings, it will also cause the mixing of 
the transitions or signals between coupled spins, such as would normally occur in a 
chemical shift correlation experiment such as COSY (via the second 90
0
 pulse). Thus, 
in a simple two hydrogen AB spin system such as citric acid, the two A transitions 
(doublet) become mixed with the two B transitions and in a tilted 2D 
1
H JRES NMR 
spectrum, signals appear in the 2D spectrum at chemical shifts where there are no 
hydrogens! It is very important to recognise these ‘artefacts’ in order to avoid mis-
assigning the spectra to non-existent metabolites with unreal J values! Figure 8 shows 
an example of this feature for citric acid itself: the 2
nd
 order signals in the 2D 
1
H JRES 
NMR spectra are marked with stars. 
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Figure 8: an expansion of the 600 MHz 2D 
1
H J-resolved NMR spectrum of the urine of a male, 30 
week old, FMO5 knockout mouse [61] in the region of the AB resonances from citric acid at ca 2.70 
and ca 2.56 ppm (four dots in 1D spectrum), displayed as a contour plot underneath the corresponding 
1D 
1
H NMR spectrum. The spectrum is tilted by 45
0
, so that all the signals of each multiplet appear at 
the same chemical shift, and symmetrised. The signals labelled with stars, appearing at ca 2.63 ppm, 
exactly in between the shifts of the two citrate signals are 2
nd
 order effects caused by the mixing of 
transitions between the A and B spins by the 180
0
 pulse, in the presence of strong coupling. As is clear 
from the 1D 
1
H NMR spectrum, there are no real signals at 2.63 ppm! 
 
Awareness of the origin of these signals allows chemical shift correlation information 
to be extracted from the 2D 
1
H JRES NMR spectrum, so these artefacts can have real 
utility in spectral assignment and metabolite structure elucidation! 
 
An important use of 2D 
1
H JRES NMR spectra is to establish the magnitude of the 
coupling constants for the 
1
H NMR signals of particular hydrogen atoms. This can 
readily be done even when the metabolites are at low levels and the signals are 
difficult to see in the 1D 
1
H NMR spectra. For example, Figure 9 shows an expansion 
from the 2D 
1
H JRES NMR spectrum of the urine of an FMO5 KO mouse at 30 
weeks age. The signals at 2.003 and 1.845 are from the two methylene hydrogens at 
C3 in 2S-hydroxyglutaric acid (HMDB00694). The chemical shifts of the two 
hydrogens are close to the values reported in the HMDB (1.985 and 1.825 
respectively) but the assignment of the two hydrogens is much more secure if the 
coupling constants can also be shown to match. In this case the 1D 
1
H NMR FID of 
the authentic metabolite was downloaded from the HMDB and reprocessed. This 
showed that the line separations in the multiplets at 1.985 and 1.825 in the authentic 
metabolite were identical to those observed at 2.005 and 1.845 in the 2D 
1
H JRES 
NMR spectrum of the urine of an FMO5 KO mouse at 30 weeks age, thus helping 
confirm this metabolite identification. 
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Figure 9: an expansion of the 600 MHz 2D 
1
H J-resolved NMR spectrum of the urine of a male, 30 
week old, FMO5 knockout mouse [61] in the region of the resonances from the C3 methylene 
hydrogens of 2S-hydroxyglutaric acid, displayed as a contour plot underneath the corresponding 1D 
1
H 
NMR spectrum. The spectrum is tilted by 45
0
, so that all the signals of each multiplet appear at the 
same chemical shift, and symmetrised. The peak picking allows a simple analysis of three of the four 
couplings that these hydrogens possess as 4.2, 6.3 and 10.5 Hz (2.003 ppm) and 5.5, 7.6 and 10.3 Hz 
(1.845 ppm). Note that these multiplets are invisible in the 1D 
1
H NMR spectrum. 
 
3.3 2D 
1
H Chemical Shift Correlation Spectroscopy (COSY) 
 
The 2D 
1
H chemical shift correlated spectroscopy (COSY) NMR experiment is a 
workhorse of metabonomics analyses for the identification of the metabolites in 
biological samples. Many variants of the 2D 
1
H COSY NMR experiment exist [35] 
but all variants provide information on which hydrogens are spin-spin coupled 
together, and this is vital for metabolite structure identification. The basic pulse 
sequence is: RD - 90
0
H - t1 - 90
0
H - FID, where RD is a relaxation delay. The first 90
0
 
pulse excites all the nuclear spins: the second 90
0
 pulse causes coherence transfer 
between the magnetisations of hydrogens which are spin-coupled to one another. The 
reason for the importance of the COSY experiment can be best illustrated with an 
example. If we observe a methyl doublet signal in a urine sample at 1.34 ppm and that 
doublet signal has a coupling constant of 6.9 Hz, we could infer that that signal 
originated from lactic acid. However, if a 2D 
1
H COSY NMR spectrum of that urine 
sample indicated that the methyl doublet at 1.34 ppm was spin-coupled to a methyne 
proton at 4.13 ppm, that would be much stronger evidence that the methyl signal was 
indeed from lactic acid. The probability of known metabolite mis-identification 
decreases strongly with each successive connected spin matched to the corresponding 
signal in the spectrum of the authentic metabolite. 
 
It is typical to run quick 2D 
1
H COSY NMR spectra with low digital resolution and 
often low sensitivity. This can be appropriate for rapid analysis of pure chemical 
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compounds but is not appropriate for metabonomics studies, as it results in the limited 
observation of hydrogen-to-hydrogen connectivities for major metabolites over 2-
bonds or three-bonds only. If the experiment is run at higher sensitivity and 
resolution, much more information can be gleaned, from a larger number of 
metabolites. Acquiring 2D COSY data at higher resolution can cost time, but this 
would not be done for every sample in a large metabonomics experiment. A high 
resolution COSY NMR spectrum would only be obtained on a handful of samples that 
are representative of the different groups in the study, with the express purpose of 
aiding metabolite identification.  
 
Using traditional methodology, a high resolution COSY spectrum might take several 
hours to acquire. For example, Figure 10 shows an expansion of the 600 MHz 2D 
1
H 
COSY NMR spectrum of the pooled urine from two FMO5 KO mice[61] at 60 weeks 
age. This experiment was acquired with spectral widths in f1 and f2 of 9578 Hz, and 
4096 points in the FID (t2) for 512 values of the evolution time (t1): the final 
spectrum was an 8192 by 2048 data matrix. The acquisition time was 0.428 sec with a 
relaxation delay of 2 sec, and 32 transients per increment of the evolution time, 
resulting in a total experiment time of just over 11 hours, which is a significant 
investment of time. However, that additional time does allow correlations via small 
couplings over 4- to 6-bonds to be observed and these can be important for metabolite 
identification, as they enable connectivities to be established between parts of 
molecular structures isolated by so-called ‘spectroscopically silent centres’. These 
silent centres are atoms with no hydrogens attached or no non-exchanging hydrogens. 
These spectroscopically silent centres break up the chains of proton-to-proton 
connectivity in a metabolite that are important for metabolite identification by e.g. 
COSY NMR. In this case the silent centre is the pyridinium nitrogen, which has no 
hydrogens bonded to it.  
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Figure 10: an expansion of the 600 MHz 2D 
1
H COSY NMR spectrum of the pooled urine of two male, 
60 week old, FMO5 knockout mice [61] in the region of the broad singlet methyl resonances from 
trigonelline at ca 4.435 and 1-methylnicotinamide ca 4.475 ppm, displayed as a contour plot 
underneath the corresponding resolution-enhanced 1D 
1
H NMR spectrum. Trigonelline displays cross-
peaks due to long-range, 4-bond coupling from the methyl protons to the H2 (9.111) and H6 (8.820) 
protons ortho to the pyridinium nitrogen. 1-methylnicotinamide displays the same cross-peaks to H2 
(9.259) and H6 (8.951), but in addition, displays a clear and remarkable cross-peak via six-bond 
coupling to H4 (8.883). The ability to connect the methyl shift with the pyridinium proton shifts in this 
way can assist metabolite identification enormously. 
 
When run at high resolution, the 2D 
1
H COSY NMR spectrum can also be used to 
identify the multiplicity of signals that are completely buried in the 1D 
1
H NMR 
spectrum, and even those that are buried in the 2D 
1
H JRES NMR spectrum. For 
example, the signal for the C4H methyne proton of ketoleucine at 2.098 ppm was 
invisible in the 1D 
1
H NMR spectrum (Figure 11 top), or in the corresponding 2D 
1
H 
J-resolved NMR spectrum of the same sample (Figure 9) but its identification is 
confirmed from the high-resolution COSY spectrum (Figure 11). 
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Figure 11: an expansion of the 600 MHz 2D 
1
H COSY NMR spectrum of the urine of a male, 30 week 
old, FMO5 knockout mouse [61] highlighting with 7 arrows the cross-peak from the C4H proton of 
ketoleucine (structure inset) at 2.098 to the equivalent C5 and C6 methyl groups at 0.941 ppm. The 
signals from ketoleucine at 2.098 are not visible either in the 1D 
1
H NMR spectrum (top), or in the 2D 
1
H J-resolved NMR spectrum of the same sample (see Figure 9) but the identification is confirmed 
from this high-resolution COSY spectrum. The seven cross peaks marked are the most intense peaks of 
the 9-line, pseudo-nonet, triplet of septets, the two outside lines of which are too weak to observe. See 
text for details. 
 
The C4H peak of ketoleucine is a triplet of septets which appears as a pseudo-nonet, 
as the coupling from C4H to the C3H2 group (7.0 Hz) is very similar to the spin-
coupling to the six equivalent methyl group protons (6.7 Hz). The two weak outside 
lines of the pseudo-nonet are weak and difficult to observe even in the authentic 
reference standard (BMRB, BMSE000383; HMDB00695 (caution the HMDB 1D 
1
H 
NMR was run at pH 3! [accessed 12 September 2015]). The high resolution COSY 
spectrum shown in Figure 11 allowed the measurement of the frequency separation of 
highest and lowest frequency lines observed in the multiplet at 2.098 as 41.4 Hz, 
which corresponded well (COSY digital resolution in f2 = 0.73 Hz) to the separation 
in authentic material: 40.8 Hz in BMSE000383, thus providing further confidence for 
the assignment of this cross-peak. 
 
The COSY experiment should always be run with good resolution in the FID (t2) as 
that resolution is essentially ‘free’. The increase in the acquisition time that this costs 
can be counterbalanced by a corresponding decrease in the relaxation delay between 
successive transients. Increasing the resolution across the second dimension, t1, does 
cost however, as does increasing the number of transients per value of the evolution 
time, and it is here that non-uniform sampling (NUS) methods and FAST NMR 
methods may lead to decreases in acquisition times in 2D NMR experiments for 
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metabolite profiling in the future. Preliminary studies show promise and we await 
developments in this area with interest. [64]  
 
3.4 2D 
1
H Total Correlation Spectroscopy (TOCSY) 
 
The 2D 
1
H TOCSY NMR experiment, sometimes called ‘homonuclear Hartmann-
Hahn spectroscopy’ (HOHAHA), is a relatively simple NMR experiment often used 
in conjunction with the COSY experiment to elucidate further structural information 
on small molecules of interest [65]. TOCSY provides similar information to a COSY 
experiment with regards to directly coupled hydrogens, but provides further structural 
information by identifying larger, interconnected groups of indirectly spin-coupled 
hydrogens.  
 
In comparison to the COSY sequence, the second 90
°
H pulse is replaced by a spin-lock 
field, applied for 10s of milliseconds, which can be considered to behave like a series 
of 180° H pulses. The spin-lock field eliminates chemical shifts during its application, 
but does not affect the scalar coupling. Due to the elimination of chemical shift 
differences in the spin-lock period, the spins are in a strong coupling regime, lose 
their individual identity and undergo magnetisation or coherence transfer. The 
magnetisation transfer that takes place is governed by the length of the spin-lock 
periods. Short spin-lock periods (20 -100 ms) yield cross peaks for directly coupled 
spins. With longer spin-lock times (100 – 300 ms), coherence will be transferred more 
remotely down chains of spin-coupled hydrogens. Thus, if we have a spin system 
AMX, where A is coupled to M and M is coupled to X, but A is not coupled to X, two 
situations can arise in the TOCSY experiment. For short spin-lock periods, 
correlations will be seen between the chemical shifts of both A and M and of M and 
X. For longer spin-lock periods, cross-peaks will also be observed between A and X, 
even though they are not directly coupled.  
 
A good example of this can be shown in N-butyrylglycine (HMDB00808) which has 
an alkyl chain three carbons long. In a COSY experiment, the protons from the 
terminal C4-methyl group (0.93 ppm) would only have cross peak correlations with 
the adjacent C3-methylene protons (1.61 ppm). However, further structural 
information for N-butyrylglycine is provided (Figure 12, see also Figures 2 and 7) 
when a cross peak is observed at the resonance of the remote C2-methylene protons 
(2.28 ppm).  
 
A one-dimensional version of the TOCSY experiment is also available. The 
experiment involves the selective excitation of a signal followed immediately by the 
application of the spin-lock field to effect coherence transfer, essentially observing a 
slice of a 2D TOCSY. Chemical shift selective filter TOCSY (CSSF-TOCSY) uses 
excitation sculpting techniques with pulse field gradients to selectively excite 
overlapping proton signals with tiny chemical shift differences, enabling reliable 
extraction of coupling constants, important in metabolite identification. 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
NMR-Based ID of Metabolites: A Guide  Page 25 
 
Figure 12. an expansion of the 600 MHz 2D 
1
H TOCSY NMR spectrum of the urine of a 30-week-old 
male C57BL/6 mouse. The cross peaks marked originate from the alkyl chain connectivities of N-
butyrylglycine, from the terminal methyl group (C4). The cross peak marked at 0.926, 1.617 ppm 
represents a direct correlation from the C4 methyl protons to the adjacent C3 methylene group, 
equivalent to the cross-peak that would be observed in a 2D 
1
H COSY experiment. Additional 
metabolite identification information is provided in this TOCSY experiment however, with the cross-
peak at 0.926, 2.279 ppm establishing a connection between the C4 methyl protons and the C2 
methylene group, even though there is no observable coupling between them.   
 
3.5 2D 
13
C, 
1
H Heteronuclear Single Quantum Correlation (HSQC) NMR 
Spectroscopy 
 
The 2D 
13
C, 
1
H Heteronuclear Single Quantum Correlation (HSQC) NMR 
Spectroscopy experiment is another fundamental experiment for metabolite 
identification. The experiment operates by correlating the chemical shifts of 
hydrogens with the chemical shifts of carbon-13 nuclei to which they are directly 
attached via 
1
JC,H. The reason that this experiment is important is two-fold. Firstly, it 
introduces a completely new and orthogonal dimension beyond 
1
H NMR to obtain 
information on the structure of metabolites: that available from the C-13 NMR 
chemical shift. Secondly, the chemical shifts of the carbon-13 nucleus extend over 
about 220 ppm for most metabolites: this is ca 20 times the range of proton NMR 
chemical shifts (ca 11 ppm), and these 
13
C NMR shifts thus provide a much more 
sensitive response to minor changes in metabolite structure than does the 
1
H NMR 
chemical shift: see Section 2.2. 
 
Many variants of the 2D 
13
C, 
1
H HSQC NMR experiment are in current usage [35] 
and its successful execution does have some challenges. All variants of this 
experiment use 
1
H detection for high sensitivity and thus, not only must the enormous 
proton signals from water be suppressed, but also all of the signals from hydrogen 
atoms that are bound to carbon-12 nuclei, which is 99% of the hydrogens in each 
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metabolite. Fortunately, the availability of high performance digital NMR 
spectrometers and gradient pulses has made the experiment routine. Indeed, new 
variants suitable for metabolite profiling in biofluids are now available that even 
provide carbon multiplicity editing as well. In these experiments, the 2D 
13
C, 
1
H 
HSQC NMR spectrum not only displays the cross-peaks due to 
1
JC,H correlations, but 
also edits the cross-peaks in a phase-sensitive fashion so that the cross-peaks due to 
methyl (CH3) and methyne (CH) moieties are of opposite phase to those of methylene 
groups (CH2). This provides tremendous power for the assignment of signals in 
crowded regions of the 
1
H NMR spectra of a biofluid: see Figure 13. 
 
 
Figure 13: an expansion of the 600 MHz, multiplicity-edited, 2D 13C, 
1
H HSQC NMR spectrum of the 
pooled urine of 60 week old, male, FMO5 knockout mice [61], displayed as a contour plot underneath 
the corresponding resolution-enhanced 1D 
1
H NMR spectrum. In this phase-sensitive plot, positive 
peaks are represented by red contours (asterisked) and negative peaks by blue contours (no asterisks). 
See text for further explanation.  
 
The multiplicity-edited, 2D 13C, 
1
H HSQC NMR spectrum in Figure 13, readily 
distinguishes the red, positive cross-peaks (asterisked) from the methyl groups of 
creatinine (3.04, 32.98), creatine (3.04, 39.71) and dimethylamine (2.73, 37.36) from 
the blue, negative cross-peaks (no asterisks) due to the methylene groups in cis-
aconitic acid (3.14, 46.34), 2-ketoglutaric acid (3.03, 38.63 and 2.45, 33.41) and 
succinic acid (2.42, 36.79). This experiment is a tremendous aid to the correct 
assignment of complex biofluid NMR spectra. 
 
3.6 2D 
13
C, 
1
H Heteronuclear Multiple Bond Correlation (HMBC) NMR 
Spectroscopy 
 
The 2D 
13
C, 
1
H Heteronuclear Multiple Correlation (HMBC) NMR Spectroscopy 
experiment [35] is another critical experiment in the identification of metabolites 
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using NMR methods. The key reason for its importance is that it enables the 
establishing of connectivities between the parts of a metabolite’s structure that are 
separated from one another by quaternary carbons or heteroatoms with no slow-
exchanging, attached hydrogens. These are the so-called ‘spectroscopically silent 
centres’ mentioned earlier. The problem is that these silent centres interrupt the chains 
of proton-to-proton connectivity between regions of protonated carbons, resulting in 
isolated fragments of structure that may not be easy to piece together. To take a 
simple example, in the molecules cis- and trans-aconitic acid, the methylene moiety is 
separated from the olefinic proton by a quaternary carbon. In this case the HMBC 
experiment can help to connect the two fragments of protonated carbon structure 
together by establishing connectivities between hydrogens and carbon separated by 
two or three bonds (Figure 14). 
 
 
 
Figure 14: an expansion of the 600 MHz 2D 13C, 
1
H HMBC NMR spectrum of the pooled urine of 
male, 60 week old, FMO5 knockout mice [61], displayed as a contour plot underneath the 
corresponding resolution-enhanced 1D 
1
H NMR spectrum in the region of the signals from the 
methylene protons of cis-aconitic acid (3.14) and trans-aconitic acid (3.47 ppm). The methylene 
protons display all four possible 2- and 3-bond hydrogen-to-carbon connectivities, to both adjacent 
carboxylic acid carbons (178.8, 182.4 ppm, trans- and 179.1 and 181.7 ppm, cis-isomer) plus 
connections to the quaternary and protonated olefinic carbons at 141.6 and 133.9 (trans-) and 146.3 and 
126.6 ppm (cis-isomer), respectively, thus establishing connectivities between the two regions of 
protonated carbon structure isolated from each other by the quaternary olefinic carbon. 
 
The HMBC experiment is critical for establishing connectivities between regions of 
protonated carbon structure when they are separated by quaternary carbons or 
heteroatoms. Although relatively insensitive, the HMBC experiment is sometimes the 
only way to obtain this information, if it is not available from alternatives such as 
high resolution COSY. 
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4. Metabolite Identification 
In this section we will bring together information obtained from 1D and 2D NMR 
experiments, together with information from metabolite databases and other sources 
to achieve metabolite identification and we will review methods for assessing the 
confidence in those metabolite identifications. There are essentially three strands to 
this activity: 1) the use of statistical methods to determine which NMR signals in a 
particular study are statistically significantly discriminating between groups of 
subjects in the study, or otherwise important, and therefore require identification and 
assignment, 2) the structure elucidation of novel metabolites, not previously described 
and 3) the structure confirmation of known metabolites. Some authors [28,66] have 
described novel metabolites as unknown unknowns and known metabolites as known 
unknowns, but this language is confusing and unhelpful: we will retain the clear and 
simple distinction between novel metabolite structure elucidation and known 
metabolite structure confirmation or identification, that has been used in molecular 
structure studies by NMR spectroscopy for decades. 
 
4.1. Identification of Significant Metabolites, or Biomarkers, using Multivariate 
Statistics 
The main objective in metabonomics is to extract relevant information from the large 
multivariate data sets. To this end pattern recognition (PR) and related multivariate 
statistical approaches can be used to discern meaningful patterns and identify 
metabolic signatures in the complex data sets that are of diagnostic or other 
classification value. A wide range of statistical methods is available today ranging 
from unsupervised methods, such as, principal component analysis (PCA), [67] or 
hierarchical clustering (HCA) [68], to supervised approaches like partial least squares 
(PLS) [69], partial least squares discriminant analysis (PLS-DA) and orthogonal 
partial least squares discriminant analysis (OPLS-DA) [70]. 
 
PCA is the most common technique in multivariate analysis that reduces the 
dimensionality of data and provides an unbiased overview of the variability in a 
dataset. In this approach samples are clustered based on their inherent 
similarity/dissimilarity with no prior knowledge of class membership. PCA represents 
most of the variance within a data set using a smaller set of variables, so-called 
principal components (PCs). Each PC is a weighted linear combination of the original 
variables, and each consecutive PC is orthogonal to the previous PC and describes the 
maximum additional variation in the data set that is not accounted for by the previous 
PCs. The results of a PCA are generally reported in terms of component scores, and 
loadings. In a scores plot, each point corresponds to a sample spectrum. Scores plots 
provide an overview of all samples and enable the visualization of groupings, trends 
and outliers. A loadings plot illustrates which variables have the greatest contribution 
to the positioning of the samples on the scores plot and are therefore responsible for 
any observed clustering of samples. Since directions in the scores plot correspond to 
directions in the loadings plot, an examination of the loadings can explain spectral 
clustering observed on the scores plot [71-73]. Usually, PCA constitutes the first step 
in metabonomic data analysis and is commonly followed by supervised pattern 
recognition techniques. These methods use class information of the samples to 
maximise the separation between different groups of samples and detect the metabolic 
signatures that contribute to the classifications.  
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One commonly used supervised method is partial least squares, also known as 
projection to latent structures (PLS), which links a data matrix of predictors usually 
comprising spectral intensity values (an X matrix), to a matrix of responses containing 
quantitative values (a Y matrix). When the response matrix is categorical, i.e. the Y 
matrix contains sample class membership information, the application of PLS 
regression is called partial least squares-discriminant analysis (PLS-DA). PLS has 
also been used in combination with a pre-processing filter termed orthogonal signal 
correction (OSC), which excludes irrelevant parts of the data that are uncorrelated 
(orthogonal) with the response, often referred to as structured noise. This structured 
noise in the data set can be caused by analytical variation or by innate physiological 
variation (e.g. different diet, age, gender). Orthogonal partial least squares 
discriminant analysis (O-PLS-DA) has an advantage over the standard PLS because it 
filters the irrelevant variation and hence enhances the model interpretation and 
identification of important variables that are responsible for the observed 
classification [73-75]. Recently, a more advanced statistical technique, Statistical 
HOmogeneous Cluster SpectroscopY (SHOCSY), has been developed which can 
better address irrelevant variation in datasets and enhance the interpretation and 
predictive ability of the OPLS-DA model via the selection of ‘truly’ representative 
samples in each biological class [76]. 
 
In supervised techniques, loading weight, variable importance on projection (VIP) 
and regression coefficient plots are used to determine the most significant 
discriminating variables. Recently, a new approach has been introduced by Cloarec et 
al. that incorporates the back-transformed loading of an auto-scaled model with the 
respective weight of each variable in the same plot. The resulting loading plot created 
in this way has the same shape as that of a spectrum with color-coded coefficients, 
according to statistical significance for each variable, which allows for easier 
interpretation of chemometric models. [77]  
 
Generally, supervised techniques are subject to overfitting, particularly in 
metabonomic studies where the number of variables is large and therefore the chance 
of false correlations is high. Proper model validation is therefore a key step to ensure 
model reliability and identification of true biomarkers. There are various validation 
methods including k-fold cross validation, permutation and test set validation. [78-81] 
Cross validation is performed in most cases, especially when the number of samples 
is low. Here, the k subset of samples is iteratively left out and predicted back into the 
model until all samples have been used once. However, truly robust model validation 
is achieved by dividing the data into a training set and a test set. The training set is 
used to construct a model and the test set is used to assess the model performance.  
 
4.2. Statistical Correlation Spectroscopy (STOCSY) 
Statistical Correlation Spectroscopy (STOCSY) follows the concept of two 
dimensional correlation spectroscopy which had originally been implemented in other 
spectroscopic techniques including fluorescence and Raman spectroscopies.[82] The 
development and adaptation of STOCSY in NMR spectra was initially performed by 
Cloarec et al. and is traditionally applied to one dimensional 
1
H NMR.[83] STOCSY 
takes advantage of the inherently linear relationship between intensity variables 
belonging to the same molecule in an NMR spectrum. It analyses the covariance of 
variables in a series of spectra and produces a correlation matrix, presented in the 
form of an NMR spectrum, which reveals the degree of correlation between each 
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variable in the spectrum (either one-dimensional or two-dimensional; see Figure 15). 
Depending on the strength of the correlation, correlated variables or resonances 
(consisting of many variables depending on the resolution) might belong to the same 
molecule (strong correlation) or molecules in the same metabolic pathway (weaker 
correlation). The correlation of each resonance, relative to the selected peak on which 
STOCSY is performed, is revealed by a colour scale which ranges from low 
correlation (typically 0) to high correlation (typically 1).[83] In the field of 
metabonomics this technique is particularly useful in the analysis of complex 
mixtures, such as urine, where the identification of metabolites can be difficult due to 
the high density of resonances and potential overlapping.[83]  
 
It is important to clarify that the ability of STOCSY to detect the correct correlations 
is affected by the degree of overlap between resonances, as well as low 
concentrations. Significant overlapping with other peaks will distort the covariance of 
different resonances belonging to the same molecule in a spectrum, while resonances 
closer to the noise level are harder to analyse. Such deficiencies have led to the 
development of other techniques including SubseT Optimization by Reference 
Matching (STORM), which uses an iterative method to calculate the correlations and 
is better suited to dealing with potential overlaps or low concentrations.[13]  
 
 
 
Figure 15: resulting NMR plot following a STOCSY analysis on a set of faecal water 
1
H-NMR spectra. 
The selected driver peak at 1.57 ppm was used to calculate the correlation matrix which reveals 
correlations ranging from 0 (low) to 1 (high). Two other resonances were revealed to have a positive 
correlation of 1, suggesting that they arise from the same molecule that was later identified as butyric 
acid. 
 
4.3. Structure Elucidation of Novel Metabolites 
If a truly novel metabolite is identified in the course of a metabonomics study, then a 
full structure elucidation to the standard generally accepted for the identification of 
novel natural products [84] or novel drug degradation products [85] is required. This 
will usually entail the isolation and purification of the novel metabolite from the 
biofluid and a full structure elucidation, typically using NMR spectroscopy, MS, 
infrared spectroscopy and ultraviolet spectroscopy, and /or the synthesis of the 
metabolite for direct comparison with the data obtained from the biofluid. 
 
4.4. Use of Information from Metabolite Databases  
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Most metabolites observed by NMR spectroscopy in metabonomics studies will be 
known, and information on a proportion of these is available in various databases such 
as the Human Metabolome Database (HMDB),[45] the BioMagResBank (BMRB) 
[86] and the Birmingham Metabolite Library (BML).[87] The HMDB is the largest 
repository of NMR and MS data on human metabolites that is currently available. As 
of September 4
th
 2015, the HMDB contained information on 41,993 metabolites. 
However, only 1,381 of these metabolites have experimental NMR data, totally 3,186 
NMR spectra. Thus, there are many metabolites for which it is not currently possible 
to access NMR data online. Databases such as the HMDB are valuable for four main 
reasons: 1) provide search facilities that allow the identification of known metabolites 
based on matches between user spectral data and database data on authentic 
metabolite samples, 2) provide interpreted 1D 
1
H and 2D NMR spectra (particularly 
2D 
13
C, 
1
H HSQC spectra) of metabolites; 3) provide access to the raw free induction 
decay data for authentic metabolites for downloading, processing and comparison 
with user data on metabolites from biofluids and 4) provide metadata on the 
metabolites and links to other databases. 
 
The 2D 
13
C, 
1
H HSQC search facility in the HMDB is particularly useful and searches 
for matches between HSQC cross-peak coordinates input by a user and those of 
authentic metabolites in the database. This is a good place to start a metabolite 
identification exercise. The user must input the tolerances for the chemical shift 
differences between the user input values and database values: metabolites whose 
cross-peak coordinates are inside those tolerances will be returned as ‘candidate 
metabolites’. Chemical shifts will naturally be different between those of an authentic 
sample in water, D2O or phosphate buffer and those of the same metabolite in a 
biofluid such as urine or plasma, but generally 
1
H NMR chemical shifts should agree 
to +/- 0.03 ppm and 
13
C NMR chemical shifts to +/- 0.5 ppm. These differences will 
increase for 
1
H or 
13
C NMR chemical shifts in metabolites which can undergo 
tautomerism [88] of any kind and the shift differences may also be larger for nuclei 
close to ionisable groups in metabolites: both these features will be sensitive to 
environment.   
 
When reviewing the candidate structures returned by the database that have HSQC 
features matching the user query, other information about the metabolite of interest 
will be used to discriminate the candidates. This information could include the 
multiplicity in the 
1
H NMR spectrum of the hydrogen giving rise to the HSQC signal, 
or connectivity information linking further elements of the metabolite structure from 
COSY or HMBC spectra. Of course, if the database search is done on just one HSQC 
cross-peak observed in the spectrum of the biofluid, ALL remaining HSQC cross-
peaks in that metabolite should also be observable in the biofluid HSQC spectrum, 
and the absence of any of the expected HSQC cross-peaks would put a question mark 
over the identification of the metabolite. On the other hand, as seen above, even 
databases as large as the HMDB are incomplete and searches will return no candidate 
structures for known metabolites if either: (i) the metabolite is not entered into the 
database, (ii) the metabolite is in the database but the relevant NMR data is not, or 
(iii) the metabolite is in the database but the relevant NMR data is not correctly 
entered. 
 
A further caveat to the use of metabolite databases is that they are only as good as the 
quality of the data entered into them. Users must beware that errors of several type are 
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present at a low level in current databases such as the HMDB, including incorrect 
samples, incorrect structures for the metabolites, impure samples and incorrect 
assignments. A good approach is to always download the original data and check it 
against expectations, and/or check the values given across more than one database 
where possible. 
 
4.5. Prediction of NMR Spectra of Metabolites for Structure Confirmation 
An ideal situation for the confident identification of known or novel metabolites 
would be to be able to predict their NMR spectra computationally without the need 
for access to authentic, real samples. In section 2.2, we saw that 
13
C NMR chemical 
shifts could be predicted by hand for simple molecules. Accurate chemical shift 
prediction would allow the expansion of databases such as the HMDB to include all 
known metabolites and the confident identification of novel as well as known 
metabolites. At present, this approach is not generally possible. Software such as 
MNova [46] and Marvin [47] allows the prediction of 
1
H and 
13
C NMR spectra. In our 
experience, these approaches are useful and somewhat successful but may fail in 
cases where the metabolite structure is complex, or is complicated by tautomerism or 
multiple sites of ionisation, and the methodology cannot always compute these with 
confidence for the relevant biological matrix. 
 
4.6. Biochemical Transformation and In Vitro Fermentation of Biofluids to Aid 
Metabolite Identification 
One successful approach to metabolite identification that is currently under-utilised is 
the biochemical transformation of unknown metabolite A in a biofluid to known 
metabolite B. This approach was used in the identification of para-cresol sulphate 
(PCS) as the key biomarker in human urine for the prediction of the metabolic fate of 
paracetamol.[5] Incubation of samples of the human urine containing PCS with a 
sulphatase enzyme led to the transformation of PCS to the known metabolite para-
cresol, which was then readily identified in this first human pharmacometabonomics 
study. 
 
A more extreme and more random, but still useful, implementation of this approach 
can occur if biofluids are left at room temperature for extended periods of time. 
Biofluids such as mouse urine will quite likely have been in contact with faecal 
material and thereby be contaminated with bacteria from the animal’s microbiome. It 
is standard practice in metabonomics studies to add a low concentration of an anti-
bacterial agent such as sodium azide to animal urine samples to inhibit bacterial 
growth, but unless the concentration of azide is high, bacterial growth may still occur. 
This will cause in vitro fermentation in the urine and will transform large numbers of 
metabolites into different but related metabolite products. For instance, bacterial 
fermentation in a sample of urine from a male FMO5 KO mouse at age 30 weeks, led 
to the 100% conversion of hippuric acid (benzoylglycine) to benzoic acid and glycine 
(Figure 16).  
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Figure 16: an expansion of the 600 MHz 
1
H NMR spectra of the urine of a male, 30 week old, FMO5 
knockout mouse [61]: 1) before bacterial fermentation and 2) after bacterial fermentation after leaving 
the sample at ambient temperature for several days. The bacterial fermentation caused many metabolic 
transformations including that of hippuric acid (hipp) to benzoic acid (b.a.) and glycine (3.57 ppm, not 
shown) and the formation of formate. The lower spectrum 1) prior to fermentation shows many signals 
including those from the ortho (7.84), para (7.64) and meta (7.56) protons of hippuric acid, whereas 
post-fermentation, spectrum 2) at top, shows corresponding signals from the ortho (7.88), para (7.56) 
and meta (7.49 ppm) protons of benzoic acid.   
 
Compared with specific enzymatic transformations, the in vitro fermentation approach 
is less specific. However, it is still a potentially useful tool to clarify metabolite 
identifications, by transforming unknown metabolites into known metabolites, or just 
to decrease crowding in a particular spectral region. 
 
4.7. Confidence Levels in Known Metabolite Identification and Confirmation of 
Known Metabolite Identity 
 
The Metabolomics Standards Initiative recognises 4 levels of known metabolite 
identification: 
 
Level 1: Identified Compound: A minimum of two independent and 
orthogonal data (such as retention time and mass spectrum) compared 
directly relative to an authentic reference standard  
Level 2: Putatively Annotated Compound: Compound identified by 
analysis of spectral data and/or similarity to data in a public database but 
without direct comparison to a reference standard as for Level 1 
Level 3: Putatively Characterised Compound Class: unidentified per se 
but the data available allows the metabolite to be placed in a compound 
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class 
Level 4: Unknown Compound: unidentified or unclassified but 
characterised by spectral data 
 
These categorisations are somewhat vague in terms of the degree of fit between the 
data on the metabolite and that on the reference standard it is being compared to. 
They have not been widely adopted since their publication in 2007,[89,90] and this 
has been commented upon recently.[91] Various modifications to the original 
categorisations have been suggested [92,93] in order to improve them but with no 
general agreement on the way forward. A call to the community was made for 
engagement with this problem.[92] Encouragingly, a new, quantitative Bayesian 
method for annotation of metabolites in LC-MS experiments has recently emerged. 
[94] New quantitative NMR spectroscopy-based proposals have also been published 
[95] that reject the notion that known metabolite identification (as opposed to putative 
annotation (Level 2)) must always be based on a direct comparison of the 
experimental data on the metabolite in a biofluid with that of an authentic reference 
standard (Level 1 above). The new methods are based on the matching of information 
obtained experimentally from NMR studies of biofluids with that contained on 
authentic metabolites in databases such as the HMDB. These methods analyse the 
amount of matching 1D and 2D 
1
H NMR spectroscopic information obtained on each 
metabolite, relative to the number of carbon atoms or heavy atoms in the molecule. 
One promising new approach is called Metabolite Identification Carbon Efficiency 
(MICE) [95] and provides a logical, quantitative and systematic method for assessing 
confidence in known metabolite identification by NMR methods.  
 
The use of metabolite database information, as opposed to information directly from 
the actual reference standards, to underpin metabolite identification is appropriate for 
NMR spectroscopy-based methods. In general, there is very good agreement between 
the chemical shifts of a metabolite in a buffered biological fluid such as urine and in a 
pure buffer solution of the same metabolite at the same pH. As mentioned in Section 
4.4 above, generally, 
1
H NMR chemical shifts should agree to +/- 0.03 ppm and 
13
C 
NMR chemical shifts to +/- 0.5 ppm for most metabolites, although there will be 
cases of metabolites with greater chemical shift sensitivity, due to the arrangement of 
ionisable groups in their molecular structures, for instance, citric acid. There will be 
an even closer agreement between the chemical shifts of a reference standard run in 
similar buffers between one laboratory and the next. Therefore access to the NMR 
spectral data on a metabolite from a database such as HMDB is, in most cases, 
equivalent to having run the NMR spectrum of that material under the same 
conditions in the user laboratory. It must be stressed however, that all database data 
should be checked for quality and for matching to the expected structure. Mistakes in 
databases do occur: users should be aware. On the other hand, for MS-based 
metabonomics approaches, such as LC-MS or UPLC-MS, the use of authentic 
reference standards is more important, due to variations in metabolite retention times 
and peak intensities that can occur in these experiments, although new methods are 
making the metabolite annotations more secure. [94] 
 
The MICE method mentioned above is one of many new variants that can be used for 
the assessment of known metabolite identification confidence. In its recommended 
HSQC-level implementation,[95] MICE counts and sums the number of bits of 
spectroscopic identification information obtained from 
1
H NMR chemical shifts, 
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multiplicities, coupling constants, second-order flags (flag = 0 if metabolite signals 
are first order; flag =1 if signals second-order [strict definition: additional lines 
present in the spectra]), 2D COSY cross-peaks and 2D HSQC cross peaks, for each 
metabolite, that match corresponding database values for the authentic metabolite. 
The MICE value is then obtained by dividing this information bit sum total by the 
number of carbon atoms in the metabolite. For example, the following signal features 
were observed for the metabolite ketoleucine, (4-methyl-2-oxopentanoic acid, 
HMDB00695, see Figure 11 and structure below), in the 600 MHz 
1
H NMR spectra 
of the urine of a male, 30 week old FMO5 knockout mouse [61]: a doublet (
3
JH,H ca 
7.0 Hz) for the H3 protons at 2.618 with a COSY to 2.098 (triplet of septets, H4), 
itself with a COSY to the equivalent methyl groups H5, and H6 at 0.941 (doublet, 6.7 
Hz) and these with an HSQC to 24.5 ppm (C5, C6). Thus for this metabolite, we 
observed 3 
1
H NMR chemical shifts, 3 multiplicities, two coupling constants, two 
COSY connectivities and one HSQC connectivity: a total of 11 pieces of information, 
all of which are a good match to the corresponding values in the HMDB. The 
guidelines for a good match are: within ±0.03 ppm for 
1
H, and ±0.5 ppm for 
13
C NMR 
shifts and ±0.2 Hz for proton couplings. There are 6 carbon atoms in the molecule, so 
the Metabolite Identification Carbon Efficiency (MICE) = 11/6 = 1.8. MICE values of 
> 1 with a good match of spectral features to those of the standard in a database are 
considered confidently identified, as in this case.  
 
 
 
Even if a known metabolite is confidently identified by NMR spectroscopy using the 
MICE methodology, it can sometimes still be important to further confirm the 
identification, especially if the particular metabolite is an important biomarker. Three 
basic approaches are frequently used: 1) authentic metabolite spiking; 2) orthogonal 
analyses using MS-based approaches and 3) isolation or purification of the metabolite 
using chromatographic procedures. Metabolite spiking involves the addition of a 
small quantity of an authentic sample of the metabolite into the biofluid of interest 
and re-running the NMR spectrum. If the metabolite is present in the biofluid, then 
the signals of the spiked material should overlap exactly with those assigned to that 
metabolite in the original biofluid. For this experiment to work optimally, spectral 
resolution and lineshape must be optimal and it is best to spike in a quantity equalling 
between 25% and 50% of the material in the biofluid: too little material spiked can 
lead to uncertainty as to whether the signals of interest have increased in intensity: too 
much material spiked may swamp the signals and lead to uncertainty as to whether 
the spike signals match those of the metabolite of interest. Liquid chromatography - 
mass spectrometry (LC-MS) or ultra performance liquid chromatography MS (UPLC-
MS)[29,30] is often used as an orthogonal confirmatory technique for metabolites 
identified by NMR spectroscopy. This joint NMR and MS approach will provide the 
maximal confidence in the identification of known biomarkers that are particularly 
H
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important. Isolation or purification procedures may use liquid chromatography, solid-
phase extraction or liquid-liquid extraction methods.[96,97] 
 
5. Conclusions and Future Thoughts 
 
Metabonomics/metabolomics is undergoing a period of very rapid technology 
development and a huge increase in the number of applications, using mainly NMR 
spectroscopy or MS detection technologies. In this guide, we have focused upon the 
metabolite identification stage of a project using NMR spectroscopy-based detection 
of metabolites. Compared with MS, NMR spectroscopy is much less sensitive, but has 
the key advantages of better spectrometer stability, absence of spectrum quenching or 
enhancement phenomena, full quantitation of metabolites and the ability to use a huge 
range of the most powerful experiments for metabolite structure elucidation. NMR-
detected metabonomics/metabolomics has been delivering answers to important 
questions in medicine, biology and other sciences for over 30 years and we 
confidently predict that it will continue to do so for decades more. 
 
Many key advances in NMR spectroscopy-based metabonomics are emerging and 
these are expected have a significant impact on the utility of the technology. We can 
highlight the following: 1) the development of highly stable digital spectrometers 
producing spectra of unparalleled quality; 2) the development of probes with multiple 
receiver coils enabling the parallelisation of some data acquisition;[98] 3) the 
development of non-uniform sampling and spatially-encoded ‘ultrafast’ methods [64] 
of 2D NMR data acquisition, which hold out the prospect that in the future the default 
metabonomics experiment may be 2D COSY or 2D J-resolved rather than the current 
standard: 1D 
1
H NMR; 4) huge advances in the computational analysis of NMR data 
in methods derived from STOCSY that hold out the prospect of a systems biology 
analysis directly from the NMR data [99] and finally 5) the use of reliable, chilled, 
NMR sample automation systems which mean that large-scale experiments on 
hundreds or thousands of samples are feasible, enabling the advent of large-scale 
phenome analyses.[12] We await this future with excitement and much anticipation. 
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7. Glossary of Terms 
 
term meaning 
1D one-dimensional 
2D two-dimensional 
90
0
H a 90 degree pulse to the 
1
H channel 
180
0
H a 180 degree pulse to the 
1
H channel 
BML Birmingham Metabolite Library 
BMRB BioMagResBank 
CAWG Chemical Analysis Working Group 
COSY COrrelation SpectroscopY 
CPMG Carr-Purcell-Meiboom-Gill 
CSSF-TOCSY Chemical Shift Selective Filter TOCSY 
δH hydrogen-1 or proton NMR chemical shift 
δC carbon-13 NMR chemical shift 
FID Free Induction Decay 
FMO5 Flavin Mono-Oxygenase 5 
GC-MS Gas Chromatography-Mass Spectrometry 
HCA Hierarchical Cluster Analysis 
HMBC Heteronuclear Multiple Bond Correlation spectroscopy 
HMDB Human Metabolome DataBase 
HOHAHA HOmonuclear HArtman HAhn 
HSQC Heteronuclear Single Quantum Correlation spectroscopy 
ID identification 
3
JH,H three-bond spin-spin coupling between two hydrogens 
JRES J-resolved spectroscopy 
KO gene Knock Out 
LC-MS Liquid Chromatography-Mass Spectrometry 
MHz MegaHertz = Hertz x 10
6
 
MICE Metabolite Identification Carbon Efficiency 
MS Mass Spectrometry 
MSI Metabolomics Standards Initiative 
NOESY nuclear Overhauser spectroscopy 
NMR Nuclear Magnetic Resonance 
O-PLS-DA Orthogonal-Partial Least Squares-Discriminant Analysis 
PC Principal Component 
PCA Principal Components Analysis 
PLS Partial Least Squares (Projection to Latent Structures) 
RD Relaxation Delay 
SHOCSY Statistical HOmogeneous Cluster SpectroscopY 
STOCSY Statistical  TOtal Correlation SpectroscopY 
STORM SubseT Optimization by Reference Matching 
t1 evolution time in a 2D NMR experiment 
t2 the acquisition time over which the FID is measured 
T1 spin-lattice relaxation time 
T2* real spin-spin relaxation time 
TOCSY TOtal Correlation SpectroscopY 
TSP sodium 3-(trimethylsilyl) propionate-2, 2, 3, 3-d4 
UPLC-MS Ultra-Performance Liquid Chromatography Mass Spectrometry 
VIP Variable Importance on Projection 
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